An interventional study of rTMS in Obsessive Compulsive Disorder (OCD) and Obsessive - Compulsive Disorder, sponsored by Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University. Recruiting at 1 site in China. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-09-30.
Sponsored by Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Obsessive-Compulsive Disorder with a site in China — 25 open to participants now, 26 under way, none of them phase 3. Obsessive-Compulsive Disorder · China.
Among the 52 studies in Obsessive-Compulsive Disorder with a site in China, this one is the 41st largest by planned enrollment of the 49 interventional ones that give a count, is one of 5 that started in 2025, is one of 40 with no phase, reaches primary completion later than 10 of the 25 other live ones, and was the 45th registered.
637 studies on the registry are indexed under Obsessive-Compulsive Disorder; 167 are open to participants now.
Browse Obsessive-Compulsive Disorder studies →25 of the 52 studies in Obsessive-Compulsive Disorder with a site in China are open now. Recruiting first, the newest first:
Shanghai Mental Health Center · Sites in China
Ages 18–55 · Healthy volunteers
Central South University · Sites in China
Ages 12–65
Peking University · Sites in China
Ages 18–65
Shanghai Mental Health Center · Sites in China
Ages 18–50
Xuanwu Hospital, Beijing · Sites in China
Ages 18–65
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 120 Obsessive-Compulsive Disorder studies recruiting now, 30 (25%) set no upper age limit and 82 (68%) stop at 75 or younger; 28 take children under 18; 19 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 4 · Phase 4 3
First in 2013; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 45 across 522 interventional studies indexed under Obsessive-Compulsive Disorder.
Median enrollment 60 across the 49 interventional studies, 30 across the 3 observational. Of the 18 that completed or were terminated, 1 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 52 have an industry lead sponsor. The 10 most frequent:
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University is the lead sponsor of 5 studies on the registry; 5 are open to participants now.
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University has 1 study filed under Obsessive-Compulsive Disorder — fewer than ten, so there is no comparison to draw.
10 of the studies in Obsessive-Compulsive Disorder with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06112067Shanghai Mental Health CenterEfficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders | 2026-11 |
| NCT07763977Guangdong Provincial People's HospitalThe Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on Inhibitory Control in Obsessive-Compulsive Disorder | 2026-12-31 |
| NCT07115615Shanghai Mental Health CenterExploring the Efficacy of Accelerated Transcranial Direct Current Stimulation (tDCS) as Adjunct to Pharmacotherapy in the Treatment of Obsessive-compulsive Disorder | 2026-12-31 |
| NCT07198594Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji UniversityAccelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder | 2026-12-31 |
| NCT07031544Shanghai Mental Health CenterEfficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder | 2027-03-31 |
Add all 10 to your calendar (.ics) → With an account.
Among the 52 studies in Obsessive-Compulsive Disorder with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if individualized accelerated repetitive transcranial magnetic stimulation (rTMS) targeting the inferior frontal cortex combined with symptom provocation works to treat obsessive-compulsive disorders (OCD) in adults. It will also learn about the safety of rTMS over right IFC. The main questions it aims to answer are:
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
individualized rTMS targeting IFC, with symptom provocation
Other: rTMS
individualized rTMS target the IFC with symptom provocation
OCD Symptom Severity Assessed by Y-BOCS
Change from Baseline to 4 weeks after treatment in OCD Symptom Severity
Time frame: From Baseline to 6 months after treatment
Safety for rTMS targeting IFC
Number of Participants with Treatment-Related Adverse Events
Time frame: Adverse Events after treatment
Depression Severity Assessed by HAMD
Time frame: From baseline to 4 weeks after treatment
Anxitey Severity Assessed by HAMA
Time frame: From Baseline to 4 weeks after treatment
Clinical Efficacy Assessed by CGI
Time frame: From Baseline to 4 weeks after treatment
Uncertainty Assessed by IUI and IUS-12
Time frame: From Baseline to 4 weeks after treatment
Self-rated Beck Depression Inventory (BDI)
Time frame: From Baseline to 4 weeks after treatment
Self-rated State-Trait Anxiety Inventory (STAI)
Time frame: From Baseline to 4 weeks after treatment
Self-rated Short UPPS-P Impulsive Behaviour Scale
Time frame: From baseline to 4 weeks after treatment
Neuroimaging by Magnetic resonance imaging
Time frame: From baseline to 4 weeks after treatment
Cognitive Function Assessent by tasks
Including Cantab and coded tasks in Matlab
Time frame: From baseline to 4 weeks after treatment
PDFs hosted by the registry, ClinicalTrials.gov.
Started Jul 2025 (actual). Primary completion is estimated for Dec 2026, 17 months after the start.
Of 235 non-industry interventional studies with no phase under Obsessive-Compulsive Disorder, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 63. This study's planned 17 months is below that.
Counting every sponsor, half of 238 studies reached it within 43 months; a quarter within 22 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Obsessive-Compulsive Disorder →
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University